Inflammatory cytokines can impair insulin signaling in some peripheral tissue, with stress stimuli, such as increased interleukins, exacerbating the progressive development of hyperglycemia and the activation of c-jun N-terminal kinase activation (JNK) and nuclear factor kappa B (NFκB), factors involved in the reduction of insulin sensitivity [5]. This evidence concerns the gene INS and Hyperglycemia.